Cargando…

The Role of Interferons in the Pathogenesis of Sjögren’s Syndrome and Future Therapeutic Perspectives

There is a great deal of evidence pointing to interferons (IFNs) as being key cytokines in the pathogenesis of different systemic autoimmune diseases, including primary Sjögren’s syndrome (pSS). In this disease, a large number of studies have shown that an overexpression of type I IFN, the ‘so-calle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Del Papa, Nicoletta, Minniti, Antonina, Lorini, Maurizio, Carbonelli, Vincenzo, Maglione, Wanda, Pignataro, Francesca, Montano, Nicola, Caporali, Roberto, Vitali, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916411/ https://www.ncbi.nlm.nih.gov/pubmed/33572487 http://dx.doi.org/10.3390/biom11020251

Ejemplares similares

Management of Sjögren's Syndrome: Present Issues and Future Perspectives
por: Vitali, Claudio, et al.
Publicado: (2021)

Instruments for Outcome Evaluation of Specific Domains in Primary Sjögren’s Syndrome
por: Del Papa, Nicoletta, et al.
Publicado: (2021)

Gene Expression Profiles in Primary Sjögren's Syndrome With and Without Systemic Manifestations
por: Vitali, Claudio, et al.
Publicado: (2019)

Taking care of systemic sclerosis patients during COVID-19 pandemic: rethink the clinical activity
por: Minniti, Antonina, et al.
Publicado: (2020)

High NEMO score values in nailfold videocapillaroscopy are associated with the subsequent development of ischaemic digital ulcers in patients with systemic sclerosis
por: Del Papa, Nicoletta, et al.
Publicado: (2020)

Impact of COVID-19 outbreak in an Italian cohort of patients with systemic sclerosis
por: Del Papa, Nicoletta, et al.
Publicado: (2020)

Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis
por: Del Papa, Nicoletta, et al.
Publicado: (2018)

Regional grafting of autologous adipose tissue is effective in inducing prompt healing of indolent digital ulcers in patients with systemic sclerosis: results of a monocentric randomized controlled study
por: Del Papa, Nicoletta, et al.
Publicado: (2019)

NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: a comparison with the proposed composite indices for this disease status entity
por: Pignataro, Francesca, et al.
Publicado: (2019)

Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19
por: Vitali, Claudio, et al.
Publicado: (2020)

Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients?
por: Del Papa, Nicoletta, et al.
Publicado: (2020)

Long Non-Coding RNAs Modulate Sjögren’s Syndrome Associated Gene Expression and Are Involved in the Pathogenesis of the Disease
por: Dolcino, Marzia, et al.
Publicado: (2019)

The cumulative number of micro-haemorrhages and micro-thromboses in nailfold videocapillaroscopy is a good indicator of disease activity in systemic sclerosis: a validation study of the NEMO score
por: Andracco, Romina, et al.
Publicado: (2017)

Quantification of Ground Glass Opacities Can Be Useful to Describe Disease Activity in Systemic Sclerosis
por: Sambataro, Domenico, et al.
Publicado: (2020)

Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis
por: Sambataro, Domenico, et al.
Publicado: (2014)

Reactome pathway analysis from whole-blood transcriptome reveals unique characteristics of systemic sclerosis patients at the preclinical stage
por: Bellocchi, Chiara, et al.
Publicado: (2023)

Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches
por: Xue, Elisabetta, et al.
Publicado: (2022)

Enhanced Tissue Factor Expression by Blood Eosinophils from Patients with Hypereosinophilia: A Possible Link with Thrombosis
por: Cugno, Massimo, et al.
Publicado: (2014)

The Role of Endothelial Progenitors in the Repair of Vascular Damage in Systemic Sclerosis
por: Del Papa, Nicoletta, et al.
Publicado: (2018)

Advances in Pathogenesis of Sjögren's Syndrome
por: Tian, Yao, et al.
Publicado: (2021)

Interferons and Dry Eye in Sjögren’s Syndrome
por: Ogawa, Yoko, et al.
Publicado: (2018)

Interferon gamma-inducible protein 16 in primary Sjögren’s syndrome: a novel player in disease pathogenesis?
por: Alunno, Alessia, et al.
Publicado: (2015)

Immunopathologic differences of Sjögren's syndrome versus sicca syndrome in HCV and HIV infection
por: Vitali, Claudio
Publicado: (2011)

The Involvement of Alarmins in the Pathogenesis of Sjögren’s Syndrome
por: Sarrand, Julie, et al.
Publicado: (2022)

Interferons in Sjögren’s Syndrome: Genes, Mechanisms, and Effects
por: Li, He, et al.
Publicado: (2013)

The potential roles of type I interferon activated neutrophils and neutrophil extracellular traps (NETs) in the pathogenesis of primary Sjögren’s syndrome
por: Peng, Yu, et al.
Publicado: (2022)

Profibrotic Effects of Endothelin-1 on Fibroblasts Are Mediated by Aldosterone In Vitro: Relevance to the Pathogenesis and Therapy of Systemic Sclerosis and Pulmonary Arterial Hypertension
por: Argentino, Giuseppe, et al.
Publicado: (2022)

Pathogenesis and treatment of Sjogren’s syndrome: Review and update
por: Zhan, Qipeng, et al.
Publicado: (2023)

IgG and IgE Autoantibodies to IgE Receptors in Chronic Spontaneous Urticaria and Their Role in the Response to Omalizumab
por: Maronese, Carlo Alberto, et al.
Publicado: (2023)

Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren’s Syndrome
por: Soyfoo, Muhammad Shahnawaz, et al.
Publicado: (2018)

Epigenetic Regulation in the Pathogenesis of Sjögren Syndrome and Rheumatoid Arthritis
por: Ibáñez-Cabellos, José Santiago, et al.
Publicado: (2019)

What is the evidence that mycobacteria are associated with the pathogenesis of Sjogren’s syndrome?
por: Dow, Coad Thomas, et al.
Publicado: (2021)

The Multiple Roles of B Cells in the Pathogenesis of Sjögren’s Syndrome
por: Du, Wenhan, et al.
Publicado: (2021)

Clinical features of Sjögren’s syndrome patients with autoantibodies against interferons
por: Burbelo, Peter D., et al.
Publicado: (2019)

Interferon Gamma Targeted Therapy: Is It Justified in Primary Sjögren’s Syndrome?
por: Sebastian, Agata, et al.
Publicado: (2022)

Sjögren syndrome: looking forward to the future
por: Zandonella Callegher, Sara, et al.
Publicado: (2022)

The Immune Factors Involved in the Pathogenesis, Diagnosis, and Treatment of Sjogren's Syndrome
por: Huang, Yi-fan, et al.
Publicado: (2013)

MicroRNA in Sjögren's Syndrome: Their Potential Roles in Pathogenesis and Diagnosis
por: Reale, M., et al.
Publicado: (2018)

Role of the Innate Immunity Signaling Pathway in the Pathogenesis of Sjögren’s Syndrome
por: Shimizu, Toshimasa, et al.
Publicado: (2021)

Sjögren Syndrome: New Insights in the Pathogenesis and Role of Nuclear Medicine
por: Kelly, Anzola Luz, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_91u1iqqtivhg3j91cq9k1h03ev